Li Z G, Manolios N
Department of Rheumatology, Royal North Shore Hospital, University of Sydney, NSW, Australia.
Aust N Z J Med. 1993 Apr;23(2):205-12. doi: 10.1111/j.1445-5994.1993.tb01817.x.
The initiation and perpetuation of many rheumatic diseases is believed to be mediated by specific T-cells activated by an unknown antigenic peptide present on the surface of antigen presenting cells (APC). The T-cell antigen receptor (TCR) plays a central role in the recognition of antigen and subsequent T-cell activation. It is thought that a selective TCR repertoire may contribute to the immunopathogenesis of certain inflammatory rheumatic diseases. In this review recent progress in our understanding of TCR usage and their role in a variety of rheumatic diseases will be discussed. In addition, novel immunotherapeutic strategies based on a better understanding of the molecular mechanisms of antigen recognition will be reviewed.
许多风湿性疾病的起始和持续被认为是由特定的T细胞介导的,这些T细胞被抗原呈递细胞(APC)表面存在的未知抗原肽激活。T细胞抗原受体(TCR)在抗原识别和随后的T细胞激活中起核心作用。据认为,选择性的TCR库可能有助于某些炎性风湿性疾病的免疫发病机制。在这篇综述中,将讨论我们对TCR使用及其在各种风湿性疾病中的作用的最新认识进展。此外,基于对抗原识别分子机制的更好理解的新型免疫治疗策略也将被综述。